Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy

scientific article published on January 2006

Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1080/08820130600745430
P698PubMed publication ID16916754

P50authorKunle OdunsiQ38296739
P2093author name stringQing Chen
Sharon S Evans
Joseph Skitzki
Michelle M Appenheimer
Wan-Chao Wang
Daniel T Fisher
P2860cites workA Toll-like receptor recognizes bacterial DNAQ24290668
Cancer immunotherapy: moving beyond current vaccinesQ24548229
Inflammation and cancerQ24649640
ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flowQ24674849
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytesQ24676216
Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancerQ24793123
Integrin avidity regulation: are changes in affinity and conformation underemphasized?Q28205914
High endothelial venules (HEVs): specialized endothelium for lymphocyte migrationQ28288508
Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic miceQ28770154
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigmQ29547181
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalQ29547865
Dissemination and growth of cancer cells in metastatic sitesQ29555846
Paradoxical roles of the immune system during cancer developmentQ29614305
The immunobiology of cancer immunosurveillance and immunoeditingQ29616246
Smoldering and polarized inflammation in the initiation and promotion of malignant diseaseQ29618034
Immunosuppressive networks in the tumour environment and their therapeutic relevanceQ29619244
Lymphocyte homing and homeostasisQ29619924
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancerQ29620068
IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation.Q33892268
Innate control of adaptive immunity via remodeling of lymph node feed arterioleQ34132263
Chemokines: immunology's high impact factorsQ34139595
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancerQ34210036
Selective imprinting of gut-homing T cells by Peyer's patch dendritic cellsQ34211233
Homing and cellular traffic in lymph nodesQ34282818
An important role for granulocytes in the thermal regulation of colon tumor growthQ34293611
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granulesQ34320910
Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breastQ34386128
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.Q34419957
Directing transition from innate to acquired immunity: defining a role for IL-6.Q34449051
Chemokines in rapid leukocyte adhesion triggering and migrationQ34615498
Dissecting tumour pathophysiology using intravital microscopyQ34632036
Spinning molecular immunology into successful immunotherapyQ34632056
JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cellsQ34646874
Model predicting survival in stage I melanoma based on tumor progressionQ34669608
Endothelial activation: intracellular signaling pathwaysQ34731148
Cytokine modified tumor vaccinesQ35027823
Rational approaches to human cancer immunotherapyQ35044144
Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway.Q40473859
Tumor-associated macrophages: the double-edged sword in cancer progression.Q40480669
Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stressQ40541651
Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigrationQ40543299
Protocols for simulating the thermal component of fever: preclinical and clinical experience.Q40545745
Cytokine and adhesion molecule expression in primary human endothelial cells stimulated with fever-range hyperthermiaQ40567151
A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse modelsQ40581761
Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venulesQ40604166
Fever-range hyperthermia stimulates alpha4beta7 integrin-dependent lymphocyte-endothelial adhesionQ40626445
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigenQ41870799
Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysisQ42457329
Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanomaQ42482085
Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitmentQ42947534
CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytesQ43808151
JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytesQ43867713
Transformation of the microvascular system during multistage tumorigenesisQ44575069
CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasisQ46090369
Leukocyte function-associated antigen 1-mediated adhesion stability is dynamically regulated through affinity and valency during bond formation with intercellular adhesion molecule-1.Q46350335
CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destructionQ47644730
Donor cell cycling, trafficking, and accumulation during adoptive immunotherapy for murine lung metastasesQ47937109
Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermiaQ50158515
Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.Q50751212
Altered patterns of T cell migration through lymph nodes and skin following antigen challengeQ52072356
Tumors as elusive targets of T-cell-based active immunotherapyQ35155955
Tumor microvasculature as a barrier to antitumor immunityQ35200590
Targeting T cell responses by selective chemokine receptor expressionQ35682772
Ligands for L-selectin: homing, inflammation, and beyondQ35698423
Lymphocyte trafficking across high endothelial venules: dogmas and enigmasQ35762431
Inflammation as a tumor promoter in cancer inductionQ35920466
Chemoattractants and their receptors in homeostasis and inflammationQ35931538
IL-6 transsignaling: the in vivo consequencesQ36116485
Immunotherapy for pancreatic cancer - science driving clinical progressQ36133140
Cancer vaccines: the challenge of developing an ideal tumor killing systemQ36170224
Dynamic control of lymphocyte trafficking by fever-range thermal stressQ36207312
The cytoplasmic domain of L-selectin interacts with cytoskeletal proteins via alpha-actinin: receptor positioning in microvilli does not require interaction with alpha-actininQ36235670
Impact of fever-range thermal stress on lymphocyte-endothelial adhesion and lymphocyte traffickingQ36246599
Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediatorsQ36247789
Cytoplasmic anchorage of L-selectin controls leukocyte capture and rolling by increasing the mechanical stability of the selectin tether.Q36294017
A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between themQ36322724
Thermal regulation of lymphocyte trafficking: hot spots of the immune responseQ36336648
Immune cell migration in inflammation: present and future therapeutic targetsQ36348737
Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinomaQ36364471
Migratory properties of naive, effector, and memory CD8(+) T cellsQ36369485
Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and primingQ36371607
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanomaQ36375683
Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissuesQ36376423
Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigrationQ36399827
Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissuesQ36402630
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumorsQ36402716
Human T cell responses against melanomaQ36427328
Regulatory T cells, tumour immunity and immunotherapyQ36430144
Role of cytokines in photodynamic therapy-induced local and systemic inflammationQ36648974
Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alphaQ37375605
Angiogenic profile of breast carcinoma determines leukocyte infiltrationQ38445307
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumorQ40412166
Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.Q40455900
P433issue3-4
P921main subjectimmunotherapyQ1427096
P304page(s)251-277
P577publication date2006-01-01
P1433published inImmunological InvestigationsQ15754982
P1476titleHurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy
P478volume35

Reverse relations

cites work (P2860)
Q37257207Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology
Q36821063Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response
Q36471557Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer.
Q41483538Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors.
Q33925291Crosstalk between medulloblastoma cells and endothelium triggers a strong chemotactic signal recruiting T lymphocytes to the tumor microenvironment
Q98237765Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma
Q43413284Endothelial plasticity governs the site-specific leukocyte recruitment in hepatocellular cancer
Q92628342Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model
Q38473933Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor
Q37274068Expression of leukotriene B₄ receptor-1 on CD8⁺ T cells is required for their migration into tumors to elicit effective antitumor immunity
Q55262681Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens.
Q38289029Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies
Q58746560ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes
Q35369944IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells
Q34989820Immune cells in the normal ovary and spontaneous ovarian tumors in the laying hen (Gallus domesticus) model of human ovarian cancer
Q58731923Intra-arterial Versus Intravenous Adoptive Cell Therapy in a Mouse Tumor Model
Q37229840Intravital imaging of CD8+ T cell function in cancer
Q37967510Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation.
Q38104594Positive and negative influence of the matrix architecture on antitumor immune surveillance
Q30268502Potential immunotherapy targets in recurrent cervical cancer
Q38122205Preconditioning thermal therapy: flipping the switch on IL-6 for anti-tumour immunity
Q33495521Quantifying cellular interaction dynamics in 3D fluorescence microscopy data
Q38284345Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy
Q37576573Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid Tissues
Q45867420Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells
Q38068003T cell-based gene therapy of cancer
Q37063499Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress
Q28073437The application of the fibroblast activation protein α-targeted immunotherapy strategy
Q38268463The glioblastoma vasculature as a target for cancer therapy
Q48892878Tracking the elusive lymphocyte: methods of detection during adoptive immunotherapy
Q37597961Tumor-mediated inhibition of dendritic cell differentiation is mediated by down regulation of protein kinase C beta II expression
Q36557847Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.
Q36038449What is the influence of vaccination's routes on the regression of tumors located at mucosal sites?

Search more.